X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with CENTURY PLYBOARDS - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs CENTURY PLYBOARDS - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES CENTURY PLYBOARDS INDOCO REMEDIES/
CENTURY PLYBOARDS
 
P/E (TTM) x 22.7 31.0 73.4% View Chart
P/BV x 2.7 14.8 18.3% View Chart
Dividend Yield % 0.8 0.5 173.3%  

Financials

 INDOCO REMEDIES   CENTURY PLYBOARDS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
CENTURY PLYBOARDS
Mar-15
INDOCO REMEDIES/
CENTURY PLYBOARDS
5-Yr Chart
Click to enlarge
High Rs360262 137.7%   
Low Rs249215 115.8%   
Sales per share (Unadj.) Rs119.071.5 166.5%  
Earnings per share (Unadj.) Rs8.46.7 124.7%  
Cash flow per share (Unadj.) Rs15.28.9 171.4%  
Dividends per share (Unadj.) Rs1.601.25 128.0%  
Dividend yield (eoy) %0.50.5 100.2%  
Book value per share (Unadj.) Rs70.717.5 403.4%  
Shares outstanding (eoy) m92.15222.17 41.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.3 76.8%   
Avg P/E ratio x36.435.6 102.5%  
P/CF ratio (eoy) x20.026.8 74.6%  
Price / Book Value ratio x4.313.6 31.7%  
Dividend payout %19.118.6 102.6%   
Avg Mkt Cap Rs m28,08352,976 53.0%   
No. of employees `0006.06.9 87.1%   
Total wages/salary Rs m2,1672,009 107.8%   
Avg. sales/employee Rs Th1,817.02,291.5 79.3%   
Avg. wages/employee Rs Th359.0289.8 123.8%   
Avg. net profit/employee Rs Th127.7214.9 59.4%   
INCOME DATA
Net Sales Rs m10,96815,884 69.0%  
Other income Rs m40177 22.4%   
Total revenues Rs m11,00716,062 68.5%   
Gross profit Rs m1,5652,559 61.1%  
Depreciation Rs m633485 130.6%   
Interest Rs m62456 13.6%   
Profit before tax Rs m9091,796 50.6%   
Minority Interest Rs m0-9 0.0%   
Prior Period Items Rs m0-1 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m139296 46.9%   
Profit after tax Rs m7711,490 51.7%  
Gross profit margin %14.316.1 88.6%  
Effective tax rate %15.316.5 92.5%   
Net profit margin %7.09.4 74.9%  
BALANCE SHEET DATA
Current assets Rs m5,7257,168 79.9%   
Current liabilities Rs m5,4545,876 92.8%   
Net working cap to sales %2.58.1 30.4%  
Current ratio x1.01.2 86.0%  
Inventory Days Days6276 81.5%  
Debtors Days Days7262 116.4%  
Net fixed assets Rs m5,3072,782 190.8%   
Share capital Rs m184223 82.8%   
"Free" reserves Rs m6,3313,522 179.8%   
Net worth Rs m6,5163,894 167.3%   
Long term debt Rs m1,323814 162.5%   
Total assets Rs m11,97010,675 112.1%  
Interest coverage x15.64.9 316.7%   
Debt to equity ratio x0.20.2 97.1%  
Sales to assets ratio x0.91.5 61.6%   
Return on assets %7.018.2 38.2%  
Return on equity %11.838.3 30.9%  
Return on capital %12.447.6 26.0%  
Exports to sales %04.2 0.0%   
Imports to sales %028.8 0.0%   
Exports (fob) Rs mNA660 0.0%   
Imports (cif) Rs mNA4,579 0.0%   
Fx inflow Rs m4,507660 683.4%   
Fx outflow Rs m1,1414,653 24.5%   
Net fx Rs m3,366-3,993 -84.3%   
CASH FLOW
From Operations Rs m8861,488 59.6%  
From Investments Rs m-1,706128 -1,333.5%  
From Financial Activity Rs m1,316-1,577 -83.4%  
Net Cashflow Rs m49739 1,270.1%  

Share Holding

Indian Promoters % 59.2 74.5 79.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 2.0 631.3%  
FIIs % 6.0 5.9 101.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 17.7 126.6%  
Shareholders   12,805 12,161 105.3%  
Pledged promoter(s) holding % 0.0 8.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   KOTHARI PRODUCTS  INGERSOLL RAND  FINOLEX IND.  INDIABULLS FIN. SER.  COMPACT DISC  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 23, 2017 10:26 AM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - TATA INVEST. CORP. COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS